Inhibin.com
Researchers Laboratories Contact Us Site Map
What is Inhibin?

Research Applications

Inhibitions

Resources

Immunoassay Kits & Research reagents

Inhibin Testing

Troubleshooting

About Us


T H E     I N H I B I N     F A M I L Y
The existence of Inhibin was proposed in 1932 by McCullagh (1). He noted that the hypertrophy of the pituitary in rats following castration was inhibited by a watersoluble testicular extract. This was later confirmed as Inhibin which inhibits the production of FSH by the anterior pituitary gland (2).

The identification of the Inhibin quickly led to the discovery of the other family members -Activin and Follistatin. It is believed that the balance of all three may be important in their endocrine function. Inhibins and Activins are member of the TGF beta superfamily. The Activins are so called because amongst their other actions, they oppose the action of Inhibins. Follistatin is a binding protein for Activin and to some extent Inhibin, whereby biological activity is neutralized in the complex. Follistatin is thought to have a regulatory role in either delivery/presentation or sequestering of the Activin molecule.(3)

 

STRUCTURE

Inhibins and Activins are highly conserved molecules which has hampered the raising of antibodies. This initially delayed research until the Groome antibodies became available. (4)

ABCs of Inhibins and Activins

*** Click here to view ABCs of Inhibins and Activins***
(  ~4.9 MB pdf document)

Inhibin is a heterodimeric glycoprotein consisting of an alpha and a beta subunit linked by disulphide bridges. Whilst the alpha subunit remains constant the different Inhibins are defined by the beta subunit – currently A and B, although other beta subunits have been proposed. The subunits can be processed in several ways to produce different isoforms. The free alpha subunit is often found in higher molar levels than the dimer in many biological fluids.

Activin is a homo- or heterodimer of the beta subunit producing Activin A, B or AB.

Follistatin is not a member of the TGF beta superfamily. It exists in two monomeric forms of 288KD and 315 KD.

 

TISSUE LOCALIZATION AND FUNCTION

It appears that dimeric Inhibin is produced by the testis in the male (B only) and ovary in the female (A and B) together with the fetoplacental unit in pregnancy (Inhibin A only). They act in direct negative feedback on pituitary production of FSH in the control of folliculogenesis and spermatogenesis.

In the testis the sertoli cells promote spermatogenesis by raising the local concentration of testosterone, under the stimulation of FSH. They produce Inhibin B as a regulatory mechanism with negative feedback on FSH at the anterior pituitary.

The granulosa cells of the developing follicle produce Inhibin B as part of the exquisite regulation that leads to follicular dominance in the menstrual cycle. Inhibin A is also produced by the follicle prior to ovulation and subsequently by the corpus luteum in the luteal phase.

The monomeric alpha subunit is produced in the brain and the adrenal gland (5,6) as are the two beta subunits which dimerise to Activin, but no dimeric Inhibin has been shown to be produced outside the gonads. Activin A is found in heart, brain, bone marrow and skeletal muscle. Activin has been implicated in embryogenesis, osteogenesis, and hematopoeisis as well as apoptosis in hepatocyte models.

Follistatin binds Activin and to some extent Inhibin. Its precise role is not yet fully established but is generally seen as a regulator of Activin, whose activity is significantly diminished when bound to Follistatin. It may be acting as a reservoir for Activins.

 

CONCLUSION

The identification of Inhibins many years after their proposed existence and the availability of research tools has allowed a greater understanding of their biological roles. Whilst the Inhibins have a focus on the reproductive axis, the Activins are found to be much more widespread with roles in the promotion of cell proliferation in differentiated tissues as well as apoptosis in hepatocytes. Follistatin is emerging as a regulatory mechanism for Activin and Inhibin may also share this role. Measurement of circulating levels of Activin and Inhibin are proving to be of clinical interest in the investigation of various reproductive disorders.

 

REFERENCES

1.McCullagh DR Science 76 19-20
2.Groome NP et al Clinical Endocrinology 1994 40 717-23
3.Burger et al Endocrinol 1988 122 1701-2
4.Nakamura et al Science 1990 Feb 16 247
5.Biliar RB et al Biol Reprod 1999 61 142-6
6.Fujimura H et al J Neuroendocrinol 1999 11 157-63

 


What is Inhibin? | Research Applications | Inhibitions | Resources | Kits & Research Reagents | Inhibin Testing | Troubleshooting | About Us
Copyright © 2003 DSL Medical Foundation, USA | Legal Terms | Privacy Statement




 Click here 
(~4.9 MB pdf document) to download a monograph that describes the molecular forms of Inhibins & Activins.



info@dslabs.com